Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18250416rdf:typepubmed:Citationlld:pubmed
pubmed-article:18250416lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C1817959lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C1149210lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:18250416lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:18250416pubmed:issue4lld:pubmed
pubmed-article:18250416pubmed:dateCreated2008-2-5lld:pubmed
pubmed-article:18250416pubmed:abstractTextThe high-affinity chain of the IL-7 receptor, IL-7Ralpha (CD127), is expressed by effector CD8 T cells that have the capacity to become memory cells. IL-7Ralpha expression is uniformly high on naive CD8 T cells, and the majority of these cells down-regulate expression upon antigenic challenge. At the peak of expansion, the fraction of effectors expressing high IL-7Ralpha varies depending on the response examined. The signals that a CD8 T cell receives during a response to Ag that lead to altered expression of IL-7Ralpha have not been fully defined. In vitro experiments demonstrated that Ag alone is sufficient to down-regulate IL-7Ralpha on all cells and most of the cells rapidly re-express the receptor upon removal from Ag. Expression was not altered by the B7.1 costimulatory ligand or when IL-12 was present to provide the signal needed for development of effector functions, indicating that TCR engagement is sufficient to regulate IL-7Ralpha expression. Consistent with this, in vivo priming with peptide Ag resulted in IL-7Ralpha expression that inversely correlated with Ag levels, and expression levels were not changed when IL-12 or adjuvant were administered with Ag. A large fraction of the cells present at the peak of expansion had re-expressed IL-7Ralpha, but most of these cells failed to survive; those that did survive expressed high IL-7Ralpha levels. Thus, Ag-dependent signals regulate IL-7Ralpha levels on responding CD8 T cells, and this occurs whether the responding cells become fully activated or are rendered tolerant by administration of peptide Ag alone.lld:pubmed
pubmed-article:18250416pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:languageenglld:pubmed
pubmed-article:18250416pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18250416pubmed:statusMEDLINElld:pubmed
pubmed-article:18250416pubmed:monthFeblld:pubmed
pubmed-article:18250416pubmed:issn0022-1767lld:pubmed
pubmed-article:18250416pubmed:authorpubmed-author:MescherMatthe...lld:pubmed
pubmed-article:18250416pubmed:authorpubmed-author:HammerbeckChr...lld:pubmed
pubmed-article:18250416pubmed:issnTypePrintlld:pubmed
pubmed-article:18250416pubmed:day15lld:pubmed
pubmed-article:18250416pubmed:volume180lld:pubmed
pubmed-article:18250416pubmed:ownerNLMlld:pubmed
pubmed-article:18250416pubmed:authorsCompleteYlld:pubmed
pubmed-article:18250416pubmed:pagination2107-16lld:pubmed
pubmed-article:18250416pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:meshHeadingpubmed-meshheading:18250416...lld:pubmed
pubmed-article:18250416pubmed:year2008lld:pubmed
pubmed-article:18250416pubmed:articleTitleAntigen controls IL-7R alpha expression levels on CD8 T cells during full activation or tolerance induction.lld:pubmed
pubmed-article:18250416pubmed:affiliationCenter for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA.lld:pubmed
pubmed-article:18250416pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18250416pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:16197entrezgene:pubmedpubmed-article:18250416lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18250416lld:entrezgene